Voyager Therapeutics, Inc. (VYGR)
NASDAQ·Healthcare·Biotechnology
$2.89
-7.96%
Mkt Cap $191.53M
Analyst Ratings
No recent rating data.
Price Target (6 analysts)
$14.40
Range $8.00 – $18.00
Implied Upside
+398.3%
Consensus $14.40 vs current $2.89
NASDAQ·Healthcare·Biotechnology
$2.89
-7.96%
Mkt Cap $191.53M
No recent rating data.
Price Target (6 analysts)
$14.40
Range $8.00 – $18.00
+398.3%
Consensus $14.40 vs current $2.89